Developments Domain Therapeutics receives multimillion-dollar milestone from Merck Domain Therapeutics, which operates in France and Canada, obtained a single-digit multimillion-dollar milestone payment from Merck as part of a €240 million collaboration and license partnership signed in 2017. Drug... June 30, 2022